2m 2m 2m 2m 2m 2m 2m
THERIVA BIO (TOVX)
NYSE
$0.19+$0.003 (+1.58%)
Price as of Oct 22, 2026 7:49 PM EDT- $9.0MMarket Cap
- -32.67%1-Year Change
- BiotechnologyIndustry
THERIVA BIO (TOVX)
$0.19+$0.003 (+1.58%)
TOVX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.19 | ||
Change | -$0.01 (-5.48%) | ||
Open | $0.20 | ||
High | $0.20 | ||
Low | $0.19 | ||
Previous Close | $0.20 | ||
Volume | 589,099 | ||
30-Day Average Volume | 493,568 | ||
1-Week Change | -6.34% | ||
1-Month Change | -14.82% | ||
1-Year Change | -32.67% | ||
3-Year Change | -98.24% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 45.9M | ||
Total Assets | $34.9M | ||
Market Cap | $9.0M | ||
Enterprise Value | -$660,502.00 | ||
Period: QTR TTM FY | |||
Revenue | $300,000.00 | ||
Net Income | -$2.0M | ||
Free Cash Flow | -$2.5M | ||
EBIT | -$2.0M | ||
EBITDA | -$2.0M | ||
Net Working Capital | $6.5M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | -12 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/27/2007 | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/26/2024 | ||
Earnings & Revenue